Enclomiphene citrate for the treatment of secondary male hypogonadism.
Rodriguez KM, Pastuszak AW, Lipshultz LI.
Expert Opin Pharmacother. 2016 Aug;17(11):1561-7. doi: 10.1080/14656566.2016.1204294. Epub 2016 Jul 4.
Obesity and male hypogonadism: Tales of a vicious cycle.
Carrageta DF, Oliveira PF, Alves MG, Monteiro MP.
Obes Rev. 2019 Aug;20(8):1148-1158. doi: 10.1111/obr.12863. Epub 2019 Apr 29.
Subclinical male hypogonadism.
Corona G, Rastrelli G, Dicuio M, Concetti S, Minnetti M, Pivonello R, Isidori A, Sforza A, Maggi M.
Minerva Endocrinol (Torino). 2021 Sep;46(3):252-261. doi: 10.23736/S2724-6507.20.03208-3. Epub 2020 Sep 24.
Metabolic Syndrome in Male Hypogonadism.
Rastrelli G, Filippi S, Sforza A, Maggi M, Corona G.
Front Horm Res. 2018;49:131-155. doi: 10.1159/000485999. Epub 2018 May 24.
Advances in the treatment of functional male hypogonadism.
Corona G, Rastrelli G, Sparano C, Vignozzi L, Sforza A, Maggi M.
Expert Rev Endocrinol Metab. 2024 Mar;19(2):163-177. doi: 10.1080/17446651.2023.2296022. Epub 2023 Dec 20.
Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach.
Rey RA, Grinspon RP, Gottlieb S, Pasqualini T, Knoblovits P, Aszpis S, Pacenza N, Stewart Usher J, Bergadá I, Campo SM.
Andrology. 2013 Jan;1(1):3-16. doi: 10.1111/j.2047-2927.2012.00008.x. Epub 2012 Oct 9.
Male hypogonadism: more than just a low testosterone.
Pantalone KM, Faiman C.
Cleve Clin J Med. 2012 Oct;79(10):717-25. doi: 10.3949/ccjm.79a.11174.
Lifestyle, metabolic disorders and male hypogonadism - A one-way ticket?
Crisóstomo L, Pereira SC, Monteiro MP, Raposo JF, Oliveira PF, Alves MG.
Mol Cell Endocrinol. 2020 Oct 1;516:110945. doi: 10.1016/j.mce.2020.110945. Epub 2020 Jul 22.
Testosterone replacement therapy.
Barbonetti A, D'Andrea S, Francavilla S.
Andrology. 2020 Nov;8(6):1551-1566. doi: 10.1111/andr.12774. Epub 2020 Mar 9.
Male hypogonadism.
UNDERDAHL LO, ALBERT A.
Postgrad Med. 1955 Apr;17(4):251-8. doi: 10.1080/00325481.1955.11711835.
